Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies

The current excitement surrounding cancer immunotherapy stems particularly from clinical data involving agents mediating immune checkpoint receptor blockade, which have induced unprecedented efficacy against a range of tumours compared with previous immunotherapeutic approaches. However, an importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Blake, Stephen J, Smyth, Mark J, Teng, Michele WL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232074/
https://www.ncbi.nlm.nih.gov/pubmed/25505970
http://dx.doi.org/10.1038/cti.2014.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232074/
https://www.ncbi.nlm.nih.gov/pubmed/25505970
http://dx.doi.org/10.1038/cti.2014.18

Ejemplares similares